![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Durable efficacy and safety of DTG + 3TC in treatment-naive people
with HIV-1 stratified by age: 144-week results from GEMINI-1 and -2
|
|
|
EACS 2021 Oct 27-30
F. Spinelli1, M. Prakash2, J. Slater1, R. Grove3, B. Wynne1, J. van Wyk2, A. Clark2
1ViiV Healthcare, Research Triangle Park, United States, 2ViiV Healthcare, Brentford, United Kingdom, 3GlaxoSmithKline, Brentford, United Kingdom
![1027211](../images/102721/102721-15/1027211.gif)
![1027212](../images/102721/102721-15/1027212.gif)
![1027213](../images/102721/102721-15/1027213.gif)
![1027214](../images/102721/102721-15/1027214.gif)
![1027215](../images/102721/102721-15/1027215.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|